## Ablation study (S-only vs P-only vs SP)
Receipt: `results/publication_suite_20251230_192215.json`

| Configuration | Pos Drug@1 | Pos Drug@1 (95% CI) | Neg PARP FP | Neg PARP FP (95% CI) | Pos N | Neg N |
|---|---:|---:|---:|---:|---:|---:|
| Rule baseline | 71.4% | (60.0%, 81.4%) | 36.7% | (20.0%, 53.3%) | 70 | 30 |
| S-only | 18.6% | (10.0%, 28.6%) | 0.0% | (0.0%, 0.0%) | 70 | 30 |
| P-only | 18.6% | (10.0%, 28.6%) | 0.0% | (0.0%, 0.0%) | 70 | 30 |
| SP (full) | 92.9% | (85.7%, 98.6%) | 0.0% | (0.0%, 0.0%) | 70 | 30 |
